1
E therapy to either placebo or nothing (the control groups) [21]. Women were recruited in Estonia from 1999?001, and followed by annually mailed questionnaires in 2000?004. Detailed descriptions of the recruitment, inclusion and exclusion criteria, trial treatment, adherence, follow-up and trial outcomes as well as the content of information leaflets and trial questionnaires have been published el
1
And. 2UKK Institute for Health Promotion Research and National Institute for Health and Welfare (THL), P.O. Box 3033501, Tampere, Finland. 3 Department of Epidemiology and Biostatistics, National Institute for Health Development, Hiiu 42, 11619, Tallinn, Estonia. Received: 15 February 2012 Accepted: 17 December 2012 Published: 21 December 2012 References 1. Hemminki E, Topo P, Kangas I: Experience
1
Uscript. RL commented the manuscript. PV participated in the designing of the analysis and commented the manuscript. All authors read and approved the final manuscript. Acknowledgement This study was partly financed by Academy of Finland grant 2007?010 (decision number 115088). We thank all women who participated in the trial, the trial staff at clinical centres, and the staff at the National Inst
1
Four "often" reported symptoms were urinary frequency (52.2 ), tiredness (45.5 ), poor sleep (27.5 ) and back pain (19.5 ). Among the women surveyed, 16.2 claimed to sometimes or often be incontinent. Referrals to the incontinence nurse increased > 8 fold during the study period. Conclusions: The PSI provides a comprehensive inventory of pregnancy related symptoms, with a mechanism for assessing
1
Used. With the current knowledge on the mixed effect on diseases, it might be feasible to find a representative cohort of new menopausal women without HT for follow-up studies.8.9.10. 11.Conclusion There was a notable variability in the development of disturbing vasomotor symptoms over time in a selected group of women aged 50 -59. Population-based followup studies of untreated women would be usef
1
R correlation from primary care research to inform study design and analysis. J Clin Epidemiol 2004, 57 (8):785?94. 52. Schulz KF, et al: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010, 63(8):834?40.doi:10.1186/1471-2393-12-155 Cite this article as: Kempler et al.: Sleep education during pregnancy for new mothers. BMC Pregnancy and Childbirt
1
E therapy to either placebo or nothing (the control groups) [21]. Women were recruited in Estonia from 1999?001, and followed by annually mailed questionnaires in 2000?004. Detailed descriptions of the recruitment, inclusion and exclusion criteria, trial treatment, adherence, follow-up and trial outcomes as well as the content of information leaflets and trial questionnaires have been published el
1
Uscript. RL commented the manuscript. PV participated in the designing of the analysis and commented the manuscript. All authors read and approved the final manuscript. Acknowledgement This study was partly financed by Academy of Finland grant 2007?010 (decision number 115088). We thank all women who participated in the trial, the trial staff at clinical centres, and the staff at the National Inst